Delaware | 85-3357217 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-half of one redeemable Warrant | HMCOU | The Nasdaq Stock Market LLC | ||
Class A Common Stock, par value $0.0001 per share | HMCO | The Nasdaq Stock Market LLC | ||
Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share | HCMOW | The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |
Emerging growth company | ☒ |
● | Part I – Item 1. Condensed Financial Statements. |
● | Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
● | Part I – Item 4. Controls and Procedures. |
● | Part II – Item 1A. Risk Factors. |
● | Part I1 – Item 6. Exhibits. |
Page | |||
1 | |||
1 | |||
1 | |||
2 | |||
3 | |||
4 | |||
5 | |||
18 | |||
19 | |||
20 |
Item 1. |
March 31, 2021 | December 31, 2020 | September 30, 2021 | December 31, 2020 | |||||||||||||
(Unaudited) | (Unaudited) | (Restated) | ||||||||||||||
ASSETS | ||||||||||||||||
Current assets | ||||||||||||||||
Cash | $ | 1,056,087 | $ | 1,193,592 | $ | 731,464 | $ | 1,193,592 | ||||||||
Prepaid expenses and other current assets | 570,642 | 625,421 | 371,100 | 625,421 | ||||||||||||
Total Current Assets | 1,626,729 | 1,819,013 | 1,102,564 | 1,819,013 | ||||||||||||
Cash and marketable securities held in Trust Account | 312,541,091 | 312,508,029 | 312,507,022 | 312,508,029 | ||||||||||||
TOTAL ASSETS | $ | 314,167,820 | $ | 314,327,042 | $ | 313,609,586 | $ | 314,327,042 | ||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||
Current liabilities | ||||||||||||||||
Accrued expenses | $ | 110,000 | $ | 67,337 | $ | 665,233 | $ | 67,337 | ||||||||
Accrued offering costs | — | 5,000 | 0 | 5,000 | ||||||||||||
Total Current Liabilities | 110,000 | 72,337 | 665,233 | 72,337 | ||||||||||||
Warrant liability | 31,133,000 | 31,607,000 | ||||||||||||||
Warrant liabilities | 25,122,000 | 31,607,000 | ||||||||||||||
Deferred underwriting fee payable | 10,062,500 | 10,062,500 | 10,062,500 | 10,062,500 | ||||||||||||
Total Liabilities | 41,305,500 | 41,741,837 | 35,849,733 | 41,741,837 | ||||||||||||
Commitments and Contingencies | 0 | 0 | ||||||||||||||
Class A common stock subject to possible redemption 26,786,231 and 26,758,520 shares at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively | 267,862,310 | 267,585,200 | ||||||||||||||
Class A common stock subject to possible redemption, $0.0001 par value; 28,750,000 shares at $10.00 per share at redemption value as of September 30, 2021 and December 31, 2020 | 287,500,000 | 287,500,000 | ||||||||||||||
Stockholders’ Equity | ||||||||||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | — | — | ||||||||||||||
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 4,463,769 and 4,491,480 shares issued and outstanding (excluding 26,786,231 and 26,758,520 shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively | 446 | 449 | ||||||||||||||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,187,500 shares issued and outstanding at March 31, 2021 and December 31, 2020 | 719 | 719 | ||||||||||||||
Stockholders’ Deficit | ||||||||||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; NaN issued or outstanding | 0 | 0 | ||||||||||||||
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 2,500,000 shares issued and outstanding (excluding 28,750,000 shares subject to possible redemption) at September 30, 2021 and December 31, 2020 | 250 | 250 | ||||||||||||||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,187,500 shares issued and outstanding at September 30, 2021 and December 31, 2020 | 719 | 719 | ||||||||||||||
Additional paid-in capital | 13,991,686 | 14,268,793 | 0 | 0 | ||||||||||||
Accumulated deficit | (8,992,841 | ) | (9,269,956 | ) | (9,741,116 | ) | (14,915,764 | ) | ||||||||
Total Stockholders’ Equity | 5,000,010 | 5,000,005 | ||||||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 314,167,820 | $ | 314,327,042 | ||||||||||||
Total Stockholders’ Deficit | (9,740,147 | ) | (14,914,795 | ) | ||||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ | 313,609,586 | $ | 314,327,042 |
Operating and formation costs | $ | 229,947 | ||
Loss from operations | (229,947 | ) | ||
Other income: | ||||
Interest earned on marketable securities held in Trust Account | 33,062 | |||
Change in fair value of warrant liability | 474,000 | |||
Other income, net | 507,062 | |||
Net income | $ | 277,115 | ||
Weighted average shares outstanding, Class A redeemable common stock | 28,750,000 | |||
Basic and diluted net income per share, Class A redeemable common stock | $ | 0.00 | ||
Weighted average shares outstanding, Class A and Class B non-redeemable common stock | 9,687,500 | |||
Basic and diluted net income per share, Class A and Class B non-redeemable common stock | $ | 0.03 |
Three Months Ended September 30, 2021 | Nine Months Ended September 30, 2021 | |||||||
General and administrative expenses | $ | 780,474 | $ | 1,354,804 | ||||
Loss from operations | (780,474 | ) | (1,354,804 | ) | ||||
Other income: | ||||||||
Income earned on marketable securities held in Trust Account | 6,423 | 44,452 | ||||||
Change in fair value of warrant liabilities | 3,081,000 | 6,485,000 | ||||||
Total other income | 3,087,423 | 6,529,452 | ||||||
Net income | $ | 2,306,949 | $ | 5,174,648 | ||||
Weighted average shares outstanding, Class A common stock | 31,250,000 | 31,250,000 | ||||||
Basic and diluted net income per share, Class A common stock | $ | 0.06 | $ | 0.13 | ||||
Weighted average shares outstanding, Class B common stock | 7,187,500 | 7,187,500 | ||||||
Basic and diluted net income per share, Class B common stock | $ | 0.06 | $ | 0.13 |
Class A Common Stock | Class B Common Stock | Additional Paid-in | Accumulated | Total Stockholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||
Balance — January 1, 2021 | 2,500,000 | $ | 250 | 7,187,500 | $ | 719 | $ | 0 | $ | (14,915,764 | ) | $ | (14,914,795 | ) | ||||||||||||||
Net income | — | 0 | — | 0 | 0 | 277,115 | 277,115 | |||||||||||||||||||||
Balance – March 31, 2021 (unaudited) | 2,500,000 | 250 | 7,187,500 | 719 | 0 | (14,638,649 | ) | (14,637,680 | ) | |||||||||||||||||||
Net income | — | 0 | — | 0 | 0 | 2,590,584 | 2,590,584 | |||||||||||||||||||||
Balance – June 30, 2021 (unaudited) | 2,500,000 | 250 | 7,187,500 | 719 | 0 | (12,048,065 | ) | (12,047,096 | ) | |||||||||||||||||||
Net income | — | 0 | — | 0 | 0 | 2,306,949 | 2,306,949 | |||||||||||||||||||||
Balance – September 30, 2021 (unaudited) | 2,500,000 | $ | 250 | 7,187,500 | $ | 719 | $ | 0 | $ | (9,741,116 | ) | $ | (9,740,147 | ) |
Class A Common Stock | Class B Common Stock | Additional Paid-in | Accumulated | Total Stockholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||||||||
Balance — January 1, 2021 | 4,491,480 | $ | 449 | 7,187,500 | $ | 719 | $ | 14,268,793 | $ | (9,269,956 | ) | $ | 5,000,005 | |||||||||||||||
Change in value of common stock subject to redemption | (27,711 | ) | (3 | ) | — | — | (277,107 | ) | — | (277,110 | ) | |||||||||||||||||
Net income | — | — | — | — | — | 277,115 | 277,115 | |||||||||||||||||||||
Balance – March 31, 2021 | 4,463,769 | $ | 446 | 7,187,500 | $ | 719 | $ | 13,991,686 | $ | (8,992,841 | ) | $ | 5,000,010 |
Cash Flows from Operating Activities: | ||||||||
Net income | $ | 277,115 | $ | 5,174,648 | ||||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
Change in fair value of warrant liability | (474,000 | ) | ||||||
Change in fair value of warrant liabilities | (6,485,000 | ) | ||||||
Interest earned on marketable securities held in Trust Account | (33,062 | ) | (44,452 | ) | ||||
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses and other current assets | 54,779 | 254,321 | ||||||
Accrued expenses | 42,663 | 597,896 | ||||||
Net cash used in operating activities | (132,505 | ) | (502,587 | ) | ||||
Cash Flows from Investing Activities: | ||||||||
Cash withdrawn from Trust Account to pay franchise and income taxes | 45,459 | |||||||
Net cash provided by investing activities | 45,459 | |||||||
Cash Flows from Financing Activities: | ||||||||
Payment of offering costs | (5,000 | ) | (5,000 | ) | ||||
Net cash used in financing activities | (5,000 | ) | (5,000 | ) | ||||
Net Change in Cash | (137,505 | ) | (462,128 | ) | ||||
Cash – Beginning of period | 1,193,592 | 1,193,592 | ||||||
Cash – End of period | $ | 1,056,087 | $ | 731,464 | ||||
Non-Cash investing and financing activities: | ||||||||
Change in value of class A common stock subject to possible redemption | $ | 277,110 |
NOTE 1. | DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
NOTE 2. | RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS |
Balance Sheet as of March 31, 2021 (unaudited) | As Previously Reported | Adjustment | As Restated | |||||||||
Class A common stock subject to possible redemption | $ | 267,862,310 | $ | 19,637,690 | $ | 287,500,000 | ||||||
Class A common stock | $ | 446 | $ | (196 | ) | $ | 250 | |||||
Additional paid-in capital | $ | 13,991,686 | $ | (13,991,686 | ) | $ | 0 | |||||
Accumulated deficit | $ | (8,992,841 | ) | $ | (5,645,808 | ) | $ | (14,638,649 | ) | |||
Total stockholders’ equity (deficit) | $ | 5,000,010 | $ | (19,637,690 | ) | $ | (14,637,680 | ) | ||||
Number of Class A shares subject to possible redemption | 26,786,231 | 1,963,769 | 28,750,000 | |||||||||
Balance Sheet as of June 30, 2021 (unaudited) | As Previously Reported | Adjustment | As Restated | |||||||||
Class A common stock subject to possible redemption | $ | 270,452,900 | $ | 17,047,100 | $ | 287,500,000 | ||||||
Class A common stock | $ | 420 | $ | (170 | ) | $ | 250 | |||||
Additional paid-in capital | $ | 11,401,122 | $ | (11,401,122 | ) | $ | 0 | |||||
Accumulated deficit | $ | (6,402,257 | ) | $ | (5,645,808 | ) | $ | (12,048,065 | ) | |||
Total stockholders’ equity (deficit) | $ | 5,000,004 | $ | (17,047,100 | ) | $ | (12,047,096 | ) | ||||
Number of Class A shares subject to possible redemption | 27,045,290 | 1,704,710 | 28,750,000 | |||||||||
Statement of Operations for the Three Months March 31, 2021 (unaudited) | As Previously Reported | Adjustment | As Restated | |||||||||
Weighted average shares outstanding, Class A common stock | 28,750,000 | 2,500,000 | 31,250,000 | |||||||||
Basic and diluted earnings per share, Class A common stock | $ | 0 | $ | 0.01 | $ | 0.01 | ||||||
Weighted average shares outstanding, Class B common stock | 9,687,500 | (2,500,000 | ) | 7,187,500 | ||||||||
Basic and diluted earnings per share, Class B common stock | $ | 0.03 | $ | (0.02 | ) | $ | 0.01 | |||||
Statement of Operations for the Three Months June 30, 2021 (unaudited) | As Previously Reported | Adjustment | As Restated | |||||||||
Weighted average shares outstanding, Class A common stock | 28,750,000 | 2,500,000 | 31,250,000 | |||||||||
Basic and diluted earnings per share, Class A common stock | $ | 0 | $ | 0.07 | $ | 0.07 | ||||||
Weighted average shares outstanding, Class B common stock | 9,687,500 | (2,500,000 | ) | 7,187,500 | ||||||||
Basic and diluted earnings per share, Class B common stock | $ | 0.27 | $ | (0.20 | ) | $ | 0.07 | |||||
Statement of Operations for the Six Months June 30, 2021 (unaudited) | As Previously Reported | Adjustment | As Restated | |||||||||
Weighted average shares outstanding, Class A common stock | 28,750,000 | 2,500,000 | 31,250,000 | |||||||||
Basic and diluted earnings per share, Class A common stock | $ | 0 | $ | 0.07 | $ | 0.07 | ||||||
Weighted average shares outstanding, Class B common stock | 9,687,500 | (2,500,000 | ) | 7,187,500 | ||||||||
Basic and diluted earnings per share, Class B common stock | $ | 0.30 | $ | (0.23 | ) | $ | 0.07 | |||||
Statement of Cash Flows for the Three Months March 31, 2021 (audited) | As Previously Reported | Adjustment | As Restated | |||||||||
Non-Cash investing and financing activities: | ||||||||||||
Change in value of Class A common stock subject to possible redemption | $ | 277,110 | $ | (277,110 | ) | $ | 0 | |||||
Statement of Cash Flows for the Six Months June 30, 2021 (audited) | As Previously Reported | Adjustment | As Restated | |||||||||
Non-Cash investing and financing activities: | ||||||||||||
Change in value of Class A common stock subject to possible redemption | $ | 2,687,700 | $ | (2,867,700 | ) | $ | 0 |
NOTE | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
Gross proceeds | $ | 287,500,000 | ||
Less: | ||||
Proceeds allocated to Public Warrants | $ | (13,943,750 | ) | |
Class A common stock issuance costs | $ | (15,513,589 | ) | |
Plus: | ||||
Accretion of carrying value to redemption value | $ | 29,457,339 | ||
Class A common stock subject to possible redemption | $ | 287,500,000 |
Three Months Ended March 31, | ||||
2021 | ||||
Redeemable Class A Common Stock | ||||
Numerator: Earnings allocable to Redeemable Class A Common Stock | ||||
Interest Income | $ | 33,062 | ||
Less: Company’s portion available to pay taxes | (33,062 | ) | ||
Net Earnings allocable to Redeemable Class A Common Stock | $ | — | ||
Denominator: Weighted Average Redeemable Class A Common Stock | ||||
Redeemable Class A Common Stock, Basic and Diluted | 28,750,000 | |||
Earnings/Basic and Diluted Redeemable Class A Common Stock | $ | 0.00 | ||
Non-Redeemable Class A and B Common Stock | ||||
Numerator: Net income minus Redeemable Net Earnings | ||||
Net Income | $ | 244,053 | ||
Interest Income | 33,062 | |||
Non-Redeemable Net Earnings | $ | 277,115 | ||
Denominator: Weighted Average Non-Redeemable Class A and B Common Stock | ||||
Non-Redeemable Class A and B Common Stock, Basic and Diluted (1) | 9,687,500 | |||
Loss/Basic and Diluted Non-Redeemable Class A and B Common Stock | $ | 0.03 |
Three Months Ended September 30, 2021 | Nine Months Ended September 30, 2021 | |||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||
Basic and diluted net income per common share | ||||||||||||||||
Numerator: | ||||||||||||||||
Allocation of net income, as adjusted | $ | 1,875,568 | $ | 431,381 | $ | 4,207,031 | $ | 967,617 | ||||||||
Denominator: | ||||||||||||||||
Basic and diluted weighted average shares outstanding | 31,250,000 | 7,187,500 | 31,250,000 | 7,187,500 | ||||||||||||
Basic and diluted net income per common share | $ | 0.06 | $ | 0.06 | $ | 0.13 | $ | 0.13 |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
NOTE | INITIAL PUBLIC OFFERING |
NOTE | PRIVATE PLACEMENT |
NOTE | RELATED PARTY TRANSACTIONS |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
NOTE | COMMITMENTS AND CONTINGENCIES |
NOTE | STOCKHOLDERS’ EQUITY |
NOTE | WARRANTS |
● | in whole and not in part; |
● | at a price of $0.01 per warrant; |
● | upon not less than 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and; |
● | if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
● | in whole and not in part; |
● | at a price of $0.10 per warrant provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares of Class A common stock determined based on the redemption date and the “fair market value” of the Company’s Class A common stock; |
● | upon a minimum of 30 days’ prior written notice of redemption; |
● | if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; |
● | if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto is available throughout the 30-day period after the written notice of redemption is given. |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
NOTE | FAIR VALUE MEASUREMENTS |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Held-To-Maturity | Amortized Cost | Gross Holding Loss | Fair Value | ||||||||||
December 31, 2020 | U.S. Treasury Securities (Matured on 3/11/2021) | $ | 312,507,938 | $ | (10,694 | ) | $ | 312,497,244 |
Held-To-Maturity | Amortized Cost | Gross Holding Loss | Fair Value | ||||||||||
December 31, 2020 | U.S. Treasury Securities (Matured on 3/11/2021) | $ | 312,507,938 | $ | (10,694 | ) | $ | 312,497,244 |
HUMANCO ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (Unaudited) |
Assets: | March 31, 2021 | December 31,2020 | September 30, 2021 | December 31, 2020 | ||||||||||||||||||||||||
Marketable securities held in Trust Account | 1 | $ | 312,541,091 | 1 | $ | 312,497,244 | 1 | $ | 312,507,022 | 1 | $ | 312,497,244 | ||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||
Warrant Liability – Public Warrants | 1 | $ | 20,312,500 | 3 | $ | 20,625,000 | 1 | $ | 16,562,500 | 3 | $ | 20,625,000 | ||||||||||||||||
Warrant Liability – Private Placement Warrants | 3 | $ | 10,820,500 | 3 | $ | 10,982,000 | 2 | $ | 8,559,500 | 3 | $ | 10,982,000 |
March 31, 2021 | December 31, 2020 | December 31, 2020 | ||||||||||
Risk-free interest rate | 1.21 | % | 0.57 | % | 0.57 | % | ||||||
Expected Term | 6.20 | 6.45 | 6.45 | |||||||||
Dividend yield | 0.00 | % | 0.00 | % | 0.00 | % | ||||||
Expected volatility | 18.3 | % | 17.5 | % | 17.5 | % | ||||||
Exercise price | $ | 11.50 | $ | 11.50 | $ | 11.50 | ||||||
Unit Price | $ | 9.95 | $ | 10.36 | $ | 10.36 |
| Private Placement | Public Warrants | Warrant Liabilities | Private Placement | Public Warrants | Warrant Liabilities | ||||||||||||||||||
Fair value as of December 31, 2020 | $ | 10,982,000 | $ | 20,625,000 | $ | 31,607,000 | ||||||||||||||||||
Fair value as of December 31, 2020 | $ | 10,982,000 | $ | 20,625,000 | $ | 31,607,000 | ||||||||||||||||||
Change in fair value | (161,500 | ) | (312,500 | ) | (474,000 | ) | (1,372,750 | ) | 0 | (1,372,750 | ) | |||||||||||||
Fair value as of March 31, 2021 | $ | 10,820,500 | $ | 20,312,500 | $ | 31,133,000 | ||||||||||||||||||
Transfer to Level 2 | (9,609,250 | ) | (9,609,250 | ) | ||||||||||||||||||||
Transfer to Level 1 | 0 | (20,625,000 | ) | (20,625,000 | ) | |||||||||||||||||||
Fair value as of September 30, 2021 | $ | 0 | $ | 0 | $ | 0 |
NOTE | SUBSEQUENT EVENTS |
Item 2. |
Item 3. |
Item 4. |
Item 1. |
Item 1A. |
Item 2. |
Item 3. |
Item 4. |
Item 5. |
Item 6. |
No. | Description of Exhibit | |
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||
101.INS* | XBRL Instance Document | |
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.SCH* | XBRL Taxonomy Extension Schema Document | |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
* | Filed herewith. |
** | Furnished herewith |
HUMANCO ACQUISITION CORP. | ||
Date: | By: | /s/ Ross Berman |
Name: | Ross Berman | |
Title: | Chief Executive Officer | |
(Principal Executive Officer) | ||
Date: | By: | /s/ Amy Zipper |
Name: | Amy Zipper | |
Title: | Chief Operating Officer | |
(Principal Financial and Accounting Officer) |